At a glance
ClinicalIndex Comparison RecordEarly Ph 1Not Yet Recruiting· 10 target
Drug / intervention
GK01 Injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-Arm Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants With Advanced Lung Cancer
In Brief
A Early Phase 1 clinical trial evaluating GK01 Injection for Advanced Lung Cancer. Not yet recruiting, targeting 10 participants across 2 sites.
Detailed Summary
A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants with Advanced Lung Cancer
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Lung Cancer
CountriesChina
Collaborators--
Timeline
Early Ph 1Not Yet Recruiting
20272028
First PostedJun 2026
Enrollment StartJul 2026
TodayJul 2026
Primary CompletionJun 2028
Study CompletionJul 2028
First PostedJun 29, 2026
Enrollment StartJul 1, 2026
Primary CompletionJun 1, 2028
Study CompletionJul 1, 2028
TodayJul 1, 2026
Enrollment to primary: 1.9 yearsPosted 2 days agoPrimary completion in 1.9 years
Interventions
GK01 Injectiondrug
Autologous tumor-reactive T cells injection